CALCICHEW D3

This brand name is authorized in Austria, Finland, Ireland, Netherlands, UK.

Active ingredients

The drug CALCICHEW D3 contains a combination of these active pharmaceutical ingredients (APIs):

1	Calcium carbonate UNII H0G9379FGK - CALCIUM CARBONATE
	Calcium carbonate releases, in a pH-dependent manner, calcium ions in the stomach. Calcium carbonate is widely used as antacid and extensively used as a dietary supplement.
	Read more about Calcium carbonate
2	Vitamin D3 UNII 1C6V77QF41 - CHOLECALCIFEROL
	In its biologically active form vitamin D3 stimulates intestinal calcium absorption, incorporation of calcium into the osteoid, and release of calcium from bone tissue. In the small intestine it promotes rapid and delayed calcium uptake. The passive and active transport of phosphate is also stimulated.
	Read more about Vitamin D3

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
A12AX	Calcium, combinations with vitamin D and/or other drugs	A Alimentary tract and metabolism → A12 Mineral supplements → A12A Calcium
Discover more medicines within A12AX

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
FI	Lääkealan turvallisuus- ja kehittämiskeskus	019874, 022213, 022222, 176974, 370269, 503220, 529604, 573439
GB	Medicines & Healthcare Products Regulatory Agency	161440, 176177, 176179, 185482, 185484, 22378, 22391, 280021, 300202, 381245, 94629
IE	Health Products Regulatory Authority	13342, 13923, 15866, 15890
NL	Z-Index G-Standaard, PRK	113506, 127655, 88463, 94145